
|Videos|July 29, 2021
Why John O'Brien Took Interest in Leading NPC
John M. O’Brien, PharmD, MPH, newly appointed President and CEO of the National Pharmaceutical Council, discusses what led to his interest in the position.
Advertisement
Pharmacy Times interviewed John M. O'Brien, PharmD, MPH, on his new role as president and CEO of the National Pharmaceutical Council (NPC).
In this discussion, O'Brien describes what brought him to be interested in taking this role at NPC. He recalls using NPC research and publications for at least 20 years, and his determination to lead a coversation based on science and evidence instead of rhetoric.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Manifestations and Prognostic Impact of Anemia in Myelofibrosis
2
Trump Announces Pricing Deals With 9 Drugmakers, Expanding Most-Favored-Nation Drug Pricing Strategy
3
Understanding Myelofibrosis and the Central Role of JAK Pathway Dysregulation
4
More Dose Adjustments, Similar Outcomes: Ribociclib vs Palbociclib in Practice
5




































































































































































































